(Q41645850)

6 October 2017

1 reference

title

Extracorporeal adsorbent-based strategies in sepsis (English)

1 reference

6 October 2017

0 references

B L Jaber

1

1 reference

6 October 2017

B J Pereira

series ordinal

2

1 reference

6 October 2017

publication date

1 November 1997

1 reference

American Journal of Kidney Diseases

6 October 2017

published in

1 reference

6 October 2017

volume

30

1 reference

6 October 2017

issue

5 Suppl 4

1 reference

6 October 2017

page(s)

S44-56

1 reference

Gram-negative bacteremia. IV. Re-evaluation of clinical features and treatment in 612 patients

6 October 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Hemofiltration in human sepsis: evidence for elimination of immunomodulatory substances

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Cytokine kinetics (TNF-alpha, IL-1 beta, IL-6) during continuous hemofiltration: a laboratory and clinical study

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Comparison of pump-driven and spontaneous continuous haemofiltration in postoperative acute renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Plasmapheresis in severe sepsis or septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Possibilities of selective and unselective adsorbent development in blood purification

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Adsorption characteristics of cellulose acetate coated charcoals

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

The use of polyamide coatings for selective adsorption control on activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Permeability of heparinized hydrophilic polymer (H-RSD): application to semipermeable membrane for microencapsulation of activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Polymer coating for hemoperfusion over activated charcoal

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Properties of binding of Escherichia coli endotoxin to various matrices.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Detoxification of plasma containing lipopolysaccharide by adsorption.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Synthetic and natural Escherichia coli free lipid A express identical endotoxic activities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Metabolic fate of endotoxin in rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Cellular distribution of endotoxin after injection of chemically purified lipopolysaccharide differs from that after injection of live bacteria

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Kinetics of endotoxin release during antibiotic therapy for experimental gram-negative bacterial sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Extracorporeal techniques of endotoxin removal: a review of the art and science

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Polymyxin and Related Peptide Antibiotics

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

The mechanism of polymyxin B action and selectivity toward biologic membranes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Polymyxin B induces transient permeability fluctuations in asymmetric planar lipopolysaccharide/phospholipid bilayers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Inactivation of endotoxin by polymyxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Binding of polymyxin B to the lipid A portion of bacterial lipopolysaccharides

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Polycations as outer membrane-disorganizing agents

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Effect of polymyxin B on experimental shock from meningococcal and Escherichia coli endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Cytokine production by human peripheral blood mononuclear cells stimulated by a Pseudomonas aeruginosa culture filtrate: role of plasma and polymyxin B

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Use of spin labels to determine the percentage of interdigitated lipid in complexes with polymyxin B and polymyxin B nonapeptide

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Nafamostat Mesylate as Anticoagulant in Continuous Hemofiltration and Continuous Hemodiafiltration

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Effect of nafamostat mesilate on bradykinin generation and hemodynamics during LDL apheresis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Induction of human interleukin-1 production by polymyxin B

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Effects of polymyxin B on superoxide anion release and priming in human polymorphonuclear leukocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Polymyxin B is a more selective inhibitor for phospholipid-sensitive Ca2+-dependent protein kinase than for calmodulin-sensitive Ca2+-dependent protein kinase

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

GPI-Anchored Cell-Surface Molecules Complexed to Protein Tyrosine Kinases

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Treatment of sepsis by extracorporeal elimination of endotoxin using polymyxin B-immobilized fiber

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Blood purification for prevention and treatment of multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Protection from endotoxemia: a rat model of plasmapheresis and specific adsorption with polymyxin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Experimental models of plasma perfusion

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Extracorporeal endotoxin removal in a canine model of septic shock

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Extracorporeal endotoxin removal by immobilized polyethylenimine.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Development of cationically modified cellulose adsorbents for the removal of endotoxins

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

The Microspheres based Detoxification System (MDS). A new extracorporeal blood purification technology based on recirculated microspherical adsorbent particles

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Microspheres based detoxification system: a new method in convective blood purification.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Small particles in medicine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Extracorporeal removal of proinflammatory cytokines by specific absorption onto microspheres

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Recombinant human interleukin 1 receptor antagonist in the treatment of patients with sepsis syndrome. Results from a randomized, double-blind, placebo-controlled trial. Phase III rhIL-1ra Sepsis Syndrome Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

Continuous veno-venous hemofiltration with dialysis removes cytokines from the circulation of septic patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

The influence of continuous hemofiltration on cytokine elimination and the cardiovascular stability in the early phase of sepsis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

The regional production of cytokines and lactate in sepsis-related multiple organ failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2897%2990542-4

7 January 2021

10.1016/S0272-6386(97)90542-4

Identifiers

DOI

0 references

1 reference